On Tuesday, Lineage Cell Therapeutics Inc (AMEX: LCTX) was -5.13% drop from the session before settling in for the closing price of $0.46. A 52-week
Lineage Cell Therapeutics Inc (AMEX: LCTX) on Tuesday, soared 2.39% from the previous trading day, before settling in for the closing price of $0.46. Within
Lineage Cell Therapeutics Inc (AMEX: LCTX) on Tuesday, soared 7.45% from the previous trading day, before settling in for the closing price of $0.40. Within
Witnessing the stock’s movement on the chart, on Wednesday, Lineage Cell Therapeutics Inc (AMEX: LCTX) had a quiet start as it plunged -2.82% to $0.42,
A new trading day began on Friday, with Lineage Cell Therapeutics Inc (AMEX: LCTX) stock price up 14.59% from the previous day of trading, before
On Friday, Lineage Cell Therapeutics Inc (AMEX: LCTX) opened higher 3.62% from the last session, before settling in for the closing price of $0.42. Price
A new trading day began on Monday, with Lineage Cell Therapeutics Inc (AMEX: LCTX) stock price down -8.19% from the previous day of trading, before
Witnessing the stock’s movement on the chart, on Thursday, Lineage Cell Therapeutics Inc (AMEX: LCTX) had a quiet start as it plunged -0.70% to $0.50,
Lineage Cell Therapeutics Inc (AMEX: LCTX) on Monday, soared 5.88% from the previous trading day, before settling in for the closing price of $0.51. Within
Lineage Cell Therapeutics Inc (AMEX: LCTX) established initial surge of 1.13% at $0.50, as the Stock market unbolted on N/A, before settling in for the
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.
